The S&P SmallCap 600 underperformed the Russell 2000 by 9% YTD, putting it on track to record its worst year of relative ...

Bioprocessing emerged from a history of extensive testing for quality assurance, but some of that is changing. Instead of an industry built on quality by testing (QbT), bioprocessing would benefit ...

The past decade has seen unparalleled growth in the field of cell therapy, which uses cells as therapeutic agents to treat and cure disease. Although the first transplants of blood stem cells date ...

In the past 10 years, the pharmaceutical industry has been moving towards a design space approach to development and manufacture – an approach that has been defined by ICHQ8, Q9 and Q10, and the ...

Luxury or necessity for developing the best biologicals? “There is the perception in biopharm companies that it is too expensive and takes too much time to implement full QbD (Quality by Design) for ...